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We report the clinical characteristics of a schizophrenia sample of 409 pedigrees—263 of European ancestry (EA)
and 146 of African American ancestry (AA)—together with the results of a genome scan (with a simple tandem
repeat polymorphism interval of 9 cM) and follow-up ﬁne mapping. A family was required to have a proband
with schizophrenia (SZ) and one or more siblings of the proband with SZ or schizoaffective disorder. Linkage
analyses included 403 independent full-sibling affected sibling pairs (ASPs) (279 EA and 124 AA) and 100 all-
possible half-sibling ASPs (15 EA and 85 AA). Nonparametric multipoint linkage analysis of all families detected
two regions with suggestive evidence of linkage at 8p23.3-q12 and 11p11.2-q22.3 (empirical Z likelihood-ratio
score [Zlr] threshold 2.65) and, in exploratory analyses, two other regions at 4p16.1-p15.32 in AA families and
at 5p14.3-q11.2 in EA families. The most signiﬁcant linkage peak was in chromosome 8p; its signal was mainly
driven by the EA families. Zlr scores 12.0 in 8p were observed from 30.7 cM to 61.7 cM (Center for Inherited
Disease Research map locations). The maximum evidence in the full sample was a multipoint Zlr of 3.25 (equivalent
Kong-Cox LOD of 2.30) near D8S1771 (at 52 cM); there appeared to be two peaks, both telomeric to neuregulin
1 (NRG1). There is a paracentric inversion common in EA individuals within this region, the effect of which on
the linkage evidence remains unknown in this and in other previously analyzed samples. Fine mapping of 8p did
not signiﬁcantly alter the signiﬁcance or length of the peak. We also performed ﬁne mapping of 4p16.3-p15.2,
5p15.2-q13.3, 10p15.3-p14, 10q25.3-q26.3, and 11p13-q23.3. The highest increase in Zlr scores was observed for
5p14.1-q12.1, where the maximum Zlr increased from 2.77 initially to 3.80 after ﬁne mapping in the EA families.
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Schizophrenia (SZ [MIM 181500]) is a disorder (or group
of disorders) with onset typically in adolescence or young
adulthood and characterized by disruption of thinking
(e.g., delusions or disorganization), perception (hallu-
cinations), mood, and behavior. The symptoms, if un-
treated, tend to persist, and the course of the disease
tends to be chronic, even with treatment. Although psy-
chotic symptoms can be detected in the general popu-
lation, and a continuum of severity from normality to
psychosis has been proposed (Strauss 1969; van Os et
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al. 2000; Johns et al. 2004), SZ, as deﬁned by the DSM-
IV criteria of the American Psychiatric Association
(1994), is widely viewed as a discrete illness. Heritability
is ∼80%, on the basis of twin studies (Cardno et al.
1999). There is a 10-fold increase in risk to ﬁrst-degree
relatives (Gottesman and Shields 1982), as well as a
familial coaggregation of SZ with other psychotic dis-
orders and with “schizophrenia spectrum” personality
disorders (Kendler et al. 1993b, 1993c, 1993d; Stompe
et al. 1998). SZ risk is also increased in adopted-away
children who have a biological parent with SZ (Heston
1966; Kety et al. 1971; Rosenthal et al. 1971) and in
the offspring of an unaffected MZ cotwin of a proband
with SZ (Gottesman and Bertelsen 1989). Complex in-
heritance is suggested by the highMZ:DZ risk ratio (∼4:
1) and by the rapid decrease in risk as biological relat-
edness to a proband decreases (O’Rourke et al. 1982).
For complex disorders such as SZ, it has proven difﬁ-
cult to obtain replicable positive evidence of genetic link-
age, but careful analysis of the SZ literature suggests that
there is considerable support for a set of potential sus-
ceptibility loci. Three types of evidence are available:
linkage statistics from published studies and from two
recent meta-analyses of genomewide linkage scans (Bad-
ner and Gershon 2002; Lewis et al. 2003), evidence from
a chromosomal deletion syndrome on chromosome 22q
(Lindsay et al. 1995), and reported associations with
positional susceptibility genes, some of which have gath-
ered independent support (Owen et al. 2004) and con-
vergent support from independent neuropharmacologi-
cal ﬁndings (Cloninger 2002). We anticipate that many
SZ susceptibility genes remain unidentiﬁed and that some
of these can be characterized using genetic linkage and
association methods. Therefore, we have recruited a large
sample of affected sibling pairs (ASPs) to search for sus-
ceptibility loci by whole-genome linkage screening, to
prioritize regions for more-intensive study. The families
were ascertained through probands with SZ who have
a sibling with SZ or schizoaffective disorder (SA). The
sample is part of the National Institute of Mental Health
(NIMH) Genetics Initiative for Schizophrenia, and the
NIMH will make available the DNA specimens and
blinded clinical data (see NIMH Center for Collabora-
tive Genetics Studies of Mental Disorders Web site).
We report here the results of a genome scan of 409
pedigrees with SZ—263 of European ancestry (EA) and
146 of African American ancestry (AA), all collected by
the Molecular Genetics of Schizophrenia (MGS1) Col-
laboration—with the use of a 9-cMmap of STRPs. Using
nonparametric multipoint linkage analysis, we detected
two chromosomal regions with suggestive evidence of
linkage (Lander and Kruglyak 1995) on chromosomes
8p23.3-p12 and 11p11.2-q22.3 in the full sample and,
in exploratory analyses, two regions that reached similar
thresholds on chromosomes 4p16.1-p15.32 and 5p14.3-
q11.2 in the AA and EA samples, respectively. Chromo-
some 8p is one of the most consistently observed regions
in SZ genome scans, as discussed below. There have been
several reports of signiﬁcant association between SZ and
polymorphisms in neuregulin 1 (NRG1) in this region
(Craddock et al. 2005), but it is not, in fact, clear to
what extent this gene accounts for the linkage signals,
and replication has not been uniform (Duan et al. 2005).
Most such linkage signals have been observed closer to
the p-telomere than to NRG1. In the present sample,
there is evidence of linkage across a broad region, and
the two peaks observed primarily in EA families are both
telomeric to NRG1. Also within this region is a para-
centric inversion that is common in Europeans (Broman
et al. 2003). A large block of linkage disequilibrium (LD)
was observed in this region in our EA sample, presum-
ably because of the absence of crossing-over when a
parent is heterozygous for the inversion. The inversion
also creates uncertainty about the location and order of
certain markers. Previous SZ linkage reports on this re-
gion have not speciﬁcally addressed the effects of this
inversion on the results. We discuss below our efforts to
accommodate this inversion.
Material and Methods
Family Ascertainment
The study participants were enrolled at nine sites in the
United States and one in Australia: University of Chicago, Chi-
cago; University of California, Irvine; University of Colorado
Health Sciences Center, Denver; Baylor College of Medicine,
Houston; University of Iowa, Iowa City; Washington Univer-
sity, St. Louis; Mount Sinai School of Medicine, New York;
University of Pennsylvania, Philadelphia (this site included a
subcontract with the Louisiana State University Health Sci-
ences Center, NewOrleans); and the University of Queensland,
Brisbane. The focus of recruitment efforts was on EA and AA
families. EA populations in the United States and Australia
have similar ethnic characteristics (Cavalli-Sforza et al. 1994).
Families were identiﬁed from a variety of sources, including
local treatment facilities, physician referrals, the National Al-
liance for the Mentally Ill and other advocacy groups, Web
sites, media announcements, and advertisements. Participants
gave informed consent to an interview, provided a blood spec-
imen for DNA and cell lines, and granted permission to obtain
their psychiatric records and (usually) to contact a family in-
formant. Available parents were asked to provide a blood spec-
imen. If one or both parents were not available, as many as
two unaffected sibs were asked to provide blood specimens.
Local institutional review board approval was obtained for each
site.
Clinical Assessment
Subjects (aged 18 years) were interviewed by trained clini-
cians using the semistructured Diagnostic Interview forGenetic
Studies (DIGS) 2.0 (Nurnberger et al. 1994), to elicit informa-
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tion required to determine diagnoses of psychotic, mood, and
substance-use disorders in accordance with DSM-IV criteria
(American Psychiatric Association 1994), the comorbidity of
these disorders, medical history, and ratings of positive and
negative symptoms of SZ. A family informant was also inter-
viewed, when possible, about each patient’s history and about
the family psychiatric history, by use of the Family Interview
for Genetic Studies (FIGS) (Gershon et al. 1988; Maxwell
1992). Two experienced research clinicians independently re-
viewed the DIGS, FIGS, interviewer’s narrative report, and all
available psychiatric records and then assigned all relevant
diagnoses (with a conﬁdence level and age at onset identiﬁed
for each one), a judgment about presence or absence of each
DSM-IV criterion for SZ and SA, and the estimated lifetime
duration of SZ and of mood syndromes. For all these items,
the diagnosticians resolved any disagreements by discussion
(or occasionally asked a third diagnostician to serve as a tie-
breaker). Thus, a primary best-estimate ﬁnal diagnosis (BEFD)
(Leckman et al. 1982) was assigned on the basis of this con-
sensus procedure. All individuals (interviewed or not) who did
not receive an SZ or SA diagnosis were considered to have
“diagnosis unknown” for the linkage analyses. One of the two
diagnosticians also completed the Lifetime Dimensions of Psy-
chosis Scale (LDPS), a 21-item scale for rating the lifetime
duration and severity of positive, bizarre positive, negative,
disorganized, and mood symptoms of psychotic disorders, on
the basis of all available information for each patient (Levinson
et al. 2002). Analyses using LDPS ratings will be presented
elsewhere.
Inclusion and Exclusion Criteria
To be eligible, a family was required to be multiplex—min-
imally, to have a proband with a BEFD of SZ and one or more
siblings with SZ or SA, with a conﬁdence level of “likely” or
“deﬁnite.” Additional ﬁrst-degree relatives with SZ and SAwere
recruited when possible. Both SZ-affected and SA-affected rel-
atives have been included in this and most other SZ linkage
studies, on the basis of evidence from multiple-family studies
showing that both disorders cluster in families ascertained
through a proband with SZ (Gershon et al. 1988; Kendler et
al. 1993a; Maier et al. 1993; Taylor et al. 1993). For an SA
diagnosis, DSM-IV requires that criteria for SZ and for manic,
mixed, and/or major depressive episodes be met simultane-
ously at some point, with persistence of psychotic symptoms
without prominent mood symptoms for at least 2 wk, and
with mood episodes persisting for “a substantial portion of
the total duration” (Cloninger et al. 1998, p. 278) of illness,
deﬁned here as 30% for consistency with the ﬁrst NIMH Ge-
netics Initiative for Schizophrenia study. Subjects were excluded
from receiving a ﬁnal diagnosis of SZ or SA if psychosis was
limited to periods of likely substance intoxication orwithdrawal,
if persistent psychotic symptoms were considered likely to be
related to substance use (e.g., increasing paranoia after years of
amphetamine use or symptoms limited to visual hallucinations
and “ﬂashbacks” after hallucinogen use), if psychosismight have
been caused by another disorder (e.g., epilepsy predating SZ
onset) as determined by consensus judgment, or if the individual
had moderate or severe mental retardation.
Diagnostic Reliability and Supplemental Clinical Measures
The cross-site reliability of diagnoses was measured by com-
paring the original site’s consensus BEFDwith a new consensus
BEFD produced blindly by a second site using blinded copies
of all available case material for 32 cases from the ﬁrst NIMH
Genetics Initiative for Schizophrenia from Washington Uni-
versity (Cloninger et al. 1998) and 36 cases from the present
study (total ). The 68 total cases included 40 with aNp 68
diagnosis of SZ from the original site, 10 with an SA diagnosis,
and 18 with mood, personality, and/or substance-use diag-
noses, most with at least some symptoms suggestive of an SZ
spectrum disorder. Cohen’s kappas (Cohen 1960) were 0.88
for SZ and 0.89 for SA, indicating no notable variation across
sites.
STRP Genotyping
DNA was extracted from lymphoblastoid cell lines by the
Rutgers University Cell and DNA Repository and was deliv-
ered in two “waves” to the Center for Inherited Disease Re-
search (CIDR) for genotyping. CIDR’s methods and details of
the CIDR map are available online (see CIDR Web site). The
marker set consisted of ∼400 STRPs, with mean spacing of 9
cM (the largest gap was 18 cM) and a mean marker hetero-
zygosity of 0.76. Family relationships were checked prior to
the scan with a forensic panel of 12 markers. Samples with
failed or very low ampliﬁcation and contaminated samples were
identiﬁed, and sex checks and a review of Mendelian discrep-
ancies were performed when required. Failed wave I specimens
were replaced when possible, and the entire family was re-
genotyped (for 23 families) in wave II. Each gel included four
CEPH controls, blind duplicates, and blank PCR products.
Over 5% of wave I specimens were genotyped a second time
in wave II. Analyses with RELCHECK (Boehnke and Cox
1997; Broman and Weber 1998) to assess family relationships
were performed with the full set of genotypes. Genotypes were
removed in cases of Mendelian inconsistencies or unlikely ge-
notypes ( ), as determined by MERLIN (multipoint en-P ! .01
gine for rapid likelihood inference) (Abecasis et al. 2002).
Quality control analyses for waves I and II, respectively, showed
missing data rates of 3.96% and 3.48%, genotypewise error
rates of 0.1% and 0.03% based on blind duplicates, and Men-
delian inconsistency rates of 0.72% and 0.67%.
Analysis of Population Substructure
Accurate estimation of marker-allele frequencies is critical
when DNA is unavailable for some parents and when popu-
lation substructure exists (Curtis and Sham 1996), and allele
frequencies can be signiﬁcantly different for EA and AA sub-
jects (Goddard et al. 2000; Grigull et al. 2001). It was decided
that separate allele-frequency estimates for these two ethnic
groups would be established for all analyses. Therefore, we
used the program STRUCTURE (Pritchard et al. 2000) to iden-
tify and exclude families that were outliers with respect to the
two main ethnic clusters, because these families would other-
wise have been analyzed with inappropriate frequency esti-
mates. Self-reported ancestries were EA or AA, plus 10 families
with Hispanic ancestry. STRUCTURE analyses were com-
pleted assuming , 3, or 4 clusters by use of all autosomalKp 2
Ta
bl
e
1
Fi
ne
-M
ap
pi
ng
Su
m
m
ar
y
V
A
L
U
E
C
H
R
O
M
O
SO
M
E
T
O
T
A
L
A
V
E
R
A
G
E
4
5
8
10
p
10
q
11
ST
R
P
Z
lr
pe
ak
gr
ou
p
A
A
E
A
E
A

A
A
E
A
E
A

A
A
E
A

A
A
…
…
Pe
ak
ST
R
P
Z
lr
2.
72
2.
77
3.
25
2.
04
2.
23
2.
74
…
…
A
pp
ro
xi
m
at
e
1-
L
O
D
lin
ka
ge
in
te
rv
al
of
ST
R
P
sc
an
(c
M
)a
:
St
ar
t
0
33
.6
2.
1
0
12
0.
3
61
.9
…
…
E
nd
35
.5
74
.3
60
.3
20
.9
17
0.
9
94
.6
…
…
To
ta
l
ap
pr
ox
im
at
e
1-
L
O
D
in
te
rv
al
(c
M
)a
35
.5
40
.7
58
.2
20
.9
50
.6
32
.7
23
8.
6
…
Fi
ne
-m
ap
pi
ng
re
gi
on
ch
os
en
(c
M
)b
:
St
ar
t
.0
24
.9
.0
.0
13
4.
7
43
.2
…
…
E
nd
43
.6
84
.0
77
.9
20
.0
17
0.
9
11
0.
1
…
…
To
ta
l
di
st
an
ce
ﬁn
e
m
ap
pe
d
(c
M
)b
43
.6
59
.1
77
.9
20
.0
36
.2
67
.0
30
4
…
C
yt
og
en
et
ic
po
si
ti
on
c
4p
16
.3
–4
p1
5.
2
5p
15
.2
–5
q1
3.
3
8p
23
.3
–8
q1
2.
1
10
p1
5.
3–
10
p1
4
10
q2
5.
3–
10
q2
6.
3
11
p1
3–
11
q2
3.
3
…
…
Ph
ys
ic
al
di
st
an
ce
(M
b)
c :
St
ar
t
.3
14
.0
.6
.3
11
6.
4
34
.9
…
…
E
nd
27
.2
75
.8
59
.5
6.
7
13
4.
0
11
6.
6
…
…
To
ta
l
di
st
an
ce
ﬁn
e
m
ap
pe
d
(M
b)
26
.8
61
.8
58
.9
6.
4
17
.7
81
.8
25
3
…
N
o.
of
ge
no
ty
pe
d
SN
Ps
91
12
0
13
1
33
71
13
9
58
5
…
In
it
ia
l
SN
P
in
te
rv
al
(c
M
)b
.4
8
.4
9
.5
9
.6
1
.5
1
.4
8
…
.5
2
N
o.
of
SN
Ps
fa
ile
d
fo
r
as
sa
y
4
4
4
1
3
3
19
…
N
o.
of
SN
Ps
fa
ile
d
fo
r
lo
w
(!
90
%
)
ge
no
ty
pi
ng
ra
te
s
6
5
5
3
0
4
23
…
N
o.
of
SN
Ps
w
it
h
ex
ce
ss
iv
e
M
en
de
lia
n
er
ro
rs
7
0
1
0
2
1
11
…
N
o.
of
SN
Ps
re
m
ai
ni
ng
w
it
h
cl
ea
n
ge
no
ty
pe
s
74
11
1
12
1
29
66
13
1
53
2
…
C
le
an
ed
SN
P
in
te
rv
al
(c
M
)b
.5
9
.5
3
.6
4
.6
9
.5
5
.5
1
…
.5
7
A
ve
ra
ge
ge
no
ty
pi
ng
ra
te
of
cl
ea
ne
d
SN
Ps
(%
)
.9
87
.9
88
.9
80
.9
88
.9
88
.9
88
…
.9
86
M
en
de
lia
n
er
ro
r
ra
te
(p
er
ge
no
ty
pe
)
of
cl
ea
ne
d
SN
Ps
(%
)
.0
00
15
.0
00
23
.0
00
12
.0
00
12
.0
00
17
.0
00
18
…
.0
00
17
U
nl
ik
el
y-
re
co
m
bi
na
nt
s
ra
te
(p
er
ge
no
ty
pe
)
of
cl
ea
ne
d
SN
Ps
(%
)
.0
00
48
.0
00
30
.0
00
42
.0
00
69
.0
00
75
.0
00
33
…
.0
00
44
A
ve
ra
ge
M
A
F
of
cl
ea
ne
d
SN
Ps
:
E
A
.3
7
.3
5
.3
6
.3
4
.3
5
.3
8
…
.3
6
A
A
.3
5
.3
4
.3
5
.3
7
.3
4
.3
5
…
.3
5
N
o.
of
cl
ea
n
SN
Ps
re
m
ov
ed
be
ca
us
e
of
de
vi
at
io
n
fr
om
H
W
E
:
E
A
1
2
0
0
1
2
6
…
A
A
0
1
3
1
0
1
6
…
N
o.
of
cl
ea
n
SN
Ps
re
m
ov
ed
be
ca
us
e
of
ad
ja
ce
nt
SN
P
L
D
:
E
A
9
21
12
6
11
13
72
…
A
A
6
5
9
3
7
12
42
…
N
o.
of
cl
ea
n
SN
Ps
re
m
ov
ed
be
ca
us
e
of
in
ve
rs
io
n
(o
nl
y
ch
ro
m
os
om
e
8)
:
E
A
0
0
5
0
0
0
5
…
A
A
0
0
5
0
0
0
5
…
N
o.
of
ﬁn
al
SN
Ps
an
al
yz
ed
fo
r
lin
ka
ge
:
E
A
64
88
10
4
23
54
11
6
44
9
…
A
A
68
10
5
10
4
25
59
11
8
47
9
…
Fi
na
l
SN
P
in
te
rv
al
(c
M
)b
:
E
A
.6
8
.6
7
.7
5
.8
7
.6
7
.5
8
…
.6
8
A
A
.6
4
.5
6
.7
5
.8
0
.6
1
.5
7
…
.6
3
Fi
na
l
ﬁn
e-
m
ap
IC
:
E
A
.8
3
.8
5
.8
5
.8
0
.8
3
.8
5
…
.8
4
A
A
.7
7
.7
8
.7
9
.7
7
.7
8
.7
8
…
.7
6
Fi
ne
-m
ap
pi
ng
Z
lr
pe
ak
gr
ou
p
A
A
E
A
E
A
E
A
E
A
E
A

A
A
…
…
Pe
ak
ﬁn
e-
m
ap
pi
ng
Z
lr
3.
09
3.
80
3.
33
2.
52
2.
08
3.
08
…
…
SN
P
ne
ar
es
t
to
pe
ak
ﬁn
e-
m
ap
pi
ng
Z
lr
rs
76
81
26
6
rs
10
27
16
4
rs
78
34
20
9
rs
11
55
93
1
rs
13
43
41
8
rs
42
75
64
7
…
…
A
pp
ro
xi
m
at
e
1-
L
O
D
in
te
rv
al
af
te
r
ﬁn
e
m
ap
pi
ng
(c
M
)b
:
St
ar
t
1.
0
44
.9
5.
1
.0
13
4.
1
69
.7
…
…
E
nd
32
.0
76
.7
46
.0
23
.2
15
3.
5
89
.2
…
…
To
ta
l
ap
pr
ox
im
at
e
1-
L
O
D
in
te
rv
al
(c
M
)b
31
.0
31
.8
40
.9
23
.2
19
.4
19
.5
16
6
…
To
ta
l
na
rr
ow
in
g
of
ﬁn
e-
m
ap
pi
ng
pe
ak
ac
hi
ev
ed
(c
M
)b
4.
5
8.
9
17
.3

2.
3
31
.2
13
.2
73
…
C
yt
og
en
et
ic
po
si
ti
on
of
ap
pr
ox
im
at
e
1-
L
O
D
in
te
rv
al
af
te
r
ﬁn
e
m
ap
pi
ng
c
4p
16
.3
–4
p1
5.
32
5p
14
.1
–5
q1
2.
1
8p
23
.2
–8
p2
1.
2
10
p1
5.
3–
10
p1
4
10
q2
5.
3–
10
q2
6.
13
11
q1
3.
1–
11
q1
4.
1
…
…
Ph
ys
ic
al
di
st
an
ce
of
ap
pr
ox
im
at
e
1-
L
O
D
in
te
rv
al
af
te
r
ﬁn
e
m
ap
pi
ng
(M
b)
c :
St
ar
t
.0
0
25
.2
2
2.
54
.0
0
11
5.
78
63
.6
9
…
…
E
nd
16
.6
5
61
.6
2
25
.9
3
9.
27
12
6.
53
82
.5
9
…
…
To
ta
l
ap
pr
ox
im
at
e
1-
L
O
D
in
te
rv
al
(M
b)
c
16
.7
36
.4
23
.4
9.
3
10
.8
18
.9
11
5
…
a
cM
va
lu
es
re
fe
r
to
th
e
ST
R
P
m
ap
of
C
ID
R
(u
se
d
fo
r
lin
ka
ge
sc
an
).
b
cM
va
lu
es
re
fe
r
to
th
e
de
C
O
D
E
m
ap
(u
se
d
fo
r
ﬁn
e
m
ap
pi
ng
).
c
C
yt
og
en
et
ic
lo
ca
ti
on
s
an
d
M
b
va
lu
es
ar
e
fr
om
th
e
U
C
SC
Ju
ly
20
03
fr
ee
ze
.
320 The American Journal of Human Genetics Volume 78 February 2006 www.ajhg.org
Table 2
Counts of Families and Individuals Genotyped
SAMPLE AND
NO. OF AFSPS PER FAMILY AFSPsa AHAPsb
Affected
Nonsibsc
Unaffected
Sibsd
NO. OF GENOTYPED PARENTS
0 1 2 3 4
EA sample:
0 AFSPs 0 15 2 5 5 8 1 0 0
1 AFSPs 226 0 6 77 81 75 70 0 0
2 AFSPs 18 0 1 5 7 7 4 0 0
3 AFSPs 4 0 1 9 2 0 1 0 1
4 AFSPs 0 0 0 0 0 0 0 0 0
5 AFSPs 1 0 0 0 1 0 0 0 0
No. of families 249 NA NA NA 96 90 76 0 1
No. of individuals or pairs 279 15 10 96 0 90 152 0 4
AA sample:
0 AFSPs 0 53 7 15 27 20 0 0 0
1 AFSPs 80 17 8 29 57 18 5 0 0
2 AFSPs 15 11 1 9 6 7 1 0 1
3 AFSPs 2 4 1 2 0 2 0 0 0
4 AFSPs 2 0 0 5 1 1 0 0 0
5 AFSPs 0 0 0 0 0 0 0 0 0
No. of families 99 NA NA NA 91 48 6 0 1
No. of individuals or pairs 124 85 16 60 0 48 12 0 4
Total sample:
No. of families 348 NA NA NA 187 138 82 0 2
No. of individuals or pairs 403 100 26 156 0 138 164 0 8
NOTE.—All counts reﬂect genotyped individuals only. A total of 1,380 individuals were genotyped in 409 families.
The number of all (genotyped or not) parents was 920 (552 EA and 368 AA). NA p not applicable.
a Genotyped independent AFSPs ( ).n 1
b Genotyped AHAPs, all possible pairs; see main text for description of this counting method.
c Genotyped affected nonsiblings; this includes persons who are not siblings or half siblings of affected individuals,
so it includes parents, aunts, uncles, and offspring.
d Genotyped unaffected siblings (and also unaffected half siblings) of affected individuals.
STRP genotypes. Each run consisted of 10,000 burn-ins and
10,000 subsequent iterations. There were clear EA and AA
clusters regardless of the value ofK,with no additional clusters
that reﬂected self-reported ethnicity. Eight of the 10 Hispanic
families consistently clustered (posterior ) with eitherP 1 .85
the EA or AA group (or showed approximately equal EA or
AA admixture). Thus, was assumed, and 10 runs ofKp 2
with different starting seeds produced no changes inKp 2
family assignments to the clusters. Thirteen families with 1 or
2 ungenotyped parents were removed from linkage analyses
because they did not attain the selected threshold of a posterior
probability of group membership of at least 0.85. Two families
with self-reported Asian ancestry (without genotyped parents)
were also removed.
Conﬁrmation of Biological Relationships
All participant-reported genetic relationships were veriﬁed
via RELCHECK (Boehnke and Cox 1997; Broman and Weber
1998) for autosomal and X-linked STRPs from the forensic
tests, and Mendelian consistency was veriﬁed via PEDCHECK
(O’Connell and Weeks 1998) for autosomal and X-linked
STRPs from the genome scan, respectively. On the basis of
these checks, 26 families were excluded because they no longer
contained an ASP (full or half) or because the “siblings” proved
to be not related, and 6 families were excluded because the
siblings had identical genotypes (because of either an unre-
ported MZ twin relationship or an error during phlebotomy,
blood submission, or processing). For the retained families,
two nuclear pedigrees contained self-reported full-sibling ASPs
that were proven to be half-sibling ASPs in the EA sample; 18
nuclear pedigrees contained self-reported full-sibling ASPs that
were proven to be half-sibling ASPs in the AA sample. Finally,
one large pedigree was split into subfamilies so that they could
be analyzed by GENEHUNTER-PLUS (GH) (Kong and Cox
1997), resulting in the creation of a “new” family; the sub-
families were treated as if they were unrelated to one another.
STRP Maps and Allele Renumbering
The STRP genotyping was performed in two waves. Brieﬂy,
in addition to three Y-linked markers and one pseudoautoso-
mal marker not used in linkage analysis, 393 autosomal and
X-linked STRPs were typed in wave I, and 400 in wave II.
Genotypes for the 387 markers common to both waves were
hand-checked for consistency of allele designations, and alleles
were renumbered when necessary, including 114 for which re-
numbering was complex (see tables A1 and A2 in appendix
A for detailed examples). For the genome-scan analysis, we
assumed map positions provided by CIDR, which are similar
to Marshﬁeld map positions (Broman et al. 1998). For the
linkage ﬁne-mapping analysis, all positions were drawn or in-
terpolated from the deCODE map (Kong et al. 2002), as dis-
cussed below.
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Table 3
Clinical Characteristics of All Genotyped Individuals
CHARACTERISTIC
PROBANDS SIBLINGS FATHERS MOTHERS OTHERSa
EA AA EA AA EA AA EA AA EA AA
No. of individuals 263 145 368 193 92 10 148 48 38 78
Percentage male 68.8 53.4 57.7 48.2 100 100 0 0 60.5 44.3
Mean (SD) age at enrollment (years) 39.1 (10.8) 41.4 (10.5) 40.6 (10.8) 43.3 (10.4) 65.5 (10.2) 69.6 (11.1) 63.3 (11.1) 60.8 (12.9) 33.9 (17.5) 38.5 (12.3)
Percentage with SZ 100 100 62.7 63.2 4.4 10.0 2.7 18.8 50.0 64.6
Percentage with SA 0 0 12.1 10.4 0 0 .7 2.1 13.2 6.3
Percentage with substance dependence:
Any:
Males 24.6 42.3 24.7 31.2 4.3 20.0 … … 17.4 34.3
Females 16.9 23.5 15.3 20.0 … … 4.1 8.3 13.3 25.0
Alcohol 15.8 26.7 12.4 15.5 4.3 20.0 2.7 4.2 5.3 16.5
Cannabis 7.5 8.2 7.0 7.3 0 0 0 2.1 5.3 6.3
Cocaine 2.3 12.3 1.6 10.9 0 0 0 0 0 8.8
Amphetamine 2.6 1.4 1.9 1.0 0 0 1.0 0 2.6 0
a The “Others” group consists of half siblings and other non–ﬁrst-degree relatives.
STRP Allele-Frequency Estimation
Maximum-likelihood allele-frequency estimates were ob-
tainedfrom the USERM13 subroutine of MENDEL (Lange et
al. 1988; Boehnke 1991) separately for the EA and AA fam-
ilies. By likelihood-ratio testing, EA and AA allele frequencies
differed at for 82.5% of the markers, at16 16P ! 10 10 
for 17% of the markers, and at for only 0.5%P .01 P 1 .01
(three) of the markers. Accordingly, for the linkage analysis
of the combined EA and AA sample, we used separate allele-
frequency estimates. For instance, if there were N alleles in the
EA sample, we renumbered the AA alleles, starting with N
. The sum of the EA and AA allele frequencies totaled 200%1
(table A2).
Linkage Analyses of STRPs and Determination of Empirical
Signiﬁcance Thresholds
Linkage analyses were performed using GH (Kong and Cox
1997) under the exponential-model option and the SALL scoring
function, to compute Z likelihood-ratio (Zlr) scores for each
map position. Zlr follows a normal distribution asymptotically
under the null hypothesis of no linkage. All results are pre-
sented on the Zlr scale. The correspondence between Zlr and
the log10 likelihood ratio of linkage is .
2LODp (Z ) /2 ln (10)lr
Information content (IC) was computed by GH. The algo-
rithm computes entropy for the probability distribution for the
inheritance vectors of all pedigrees with or without genotypic
data. IC is then computed by subtracting the ratio of these
terms from 1. Map locations were drawn from the CIDR map
(Broman et al. 1998) or were interpolated into that map.
The linkage analysis of all families combined was considered
to be the primary analysis. Exploratory analyses of the EA and
AA families separately were also performed. To determine em-
pirical signiﬁcance thresholds for Zlr scores, 5,000 replicates
of the actual sample, map, and allele frequencies (including
patterns of missing data) were generated using SIMULATE
(Terwilliger et al. 1993) under the assumption of an absence
of linkage. Each replicate was analyzed separately for all fam-
ilies (the planned primary analysis) and then for the AA and
EA families separately. For the primary analysis, the Zlr thresh-
old was 3.60 for “signiﬁcant” linkage (expected in 5% of
genome scans) and 2.65 for “suggestive” linkage (expected1
times per genome scan) (Holmans et al. 2004). In comparison,
the thresholds for EA and AA samples (without correction for
multiple testing) were similar: 3.62 and 3.63, respectively, for
signiﬁcant linkage and 2.71 and 2.69, respectively, for sugges-
tive linkage.
Also, as discussed below, a common paracentric inversion
has been reported (Broman et al. 2003) in the region of chro-
mosome 8p that produced the greatest evidence of linkage in
the present study. One STRP in the CIDR map (D8S1469) is
located in the middle of the typical inversion segment, and an-
other STRP in the CIDR map (D8S1130) is close to the bound-
ary of the typical inversion segment. The exact positions of
these two STRPs, and the probability of recombination around
them, would differ in individuals with and individuals without
the inversion. The primary genome scan analysis results re-
ported below excluded D8S1469, the less informative of the
two inversion STRPs.
SNP Genotyping and Data Cleaning
For linkage ﬁne mapping, genotyping of SNP markers was
performed at Evanston Northwestern Healthcare’s Center for
Psychiatric Genetics (Evanston, IL) by use of SNPlex (Applied
Biosystems [ABI]). Using SNPbrowser software, version 1.0
(ABI), 585 SNPs (13 SNPlex pools) were selected to form a
0.5–0.6-cM map across 304 cM (255 Mb [Matise et al. 2003])
of chromosomes 4p16.3-p15.2 (44 cM; 27Mb), 5p15.2-q13.3
(59 cM; 62 Mb), 8p23.3-q12.1 (78 cM; 59 Mb), 10p15.3-p14
(20 cM; 7 Mb), 10q25.3-q26.3 (36 cM; 18 Mb), and 11p13-
q23.3 (67 cM; 82 Mb) from HapMap, Celera (Venter et al.
2001), or public databases (see National Center for Biotech-
nology Information [NCBI] dbSNP Web site, build 34) (table
1). Validated SNPs were selected if their minor-allele frequency
(MAF) was reported to be 125% in databases for both EA
and AA samples, and they were tested using bioinformatics
for suitability for the SNPlex assay. Forty nanograms of frag-
mented DNAwas dried down on each well of a 384-well plate.
After phosphorylation of oligonucleotide ligation assay probes
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Table 4
Additional Clinical Characteristics of Genotyped Affected Subjects
AFFECTED GROUP
AND CHARACTERISTIC
PROBANDS SIBLINGS
EA AA EA AA
Males Females Males Females Males Females Males Females
SZ:
No. of individuals 182 81 78 67 155 77 66 54
Mean age at enrollment (years) 37.7 42.2 40.0 43.1 38.2 42.1 43.2 42.5
Mean age at illness onset (years) 20.3 20.3 19.6 22.2 20.1 21.1 19.3 20.3
Mean duration of nonaffective psychosis (mo) 207.5 258.9 238.1 253.9 215.4 246.6 276.4 253.9
Percentage of subjects with mood episodes 46.4 64.6 38.2 61.8 51.3 64.9 42.4 69.1
Mean duration of mood episodes (mo) 11.6 23.5 13.1 13.1 13.2 13.1 14.0 16.8
SA:
No. of individuals 24 21 8 12
Mean age at enrollment (years) 40.0 41.8 35.4 41.8
Mean age at illness onset (years) 21.1 21.9 18.1 19.3
Mean duration of nonaffective psychosis (mo) 218.4 234.3 182.6 222.4
Mean duration of mood episodesa (mo) 94.8 123.6 89.3 115.7
a All subjects with SA had one or more mood episodes (manic, mixed, and/or major depressive), by deﬁnition.
and universal linkers, allele-speciﬁc ligation and enzymatic
clean-up were performed. PCR was performed with universal
primers, and biotinylated amplicons were captured on strep-
tavidin-coated plates. Single-stranded PCR products were hy-
bridized with a set of ﬂuorescently labeled, universal ZipChute
probes that have a unique sequence corresponding to each SNP.
ZipChute probes were eluted and separated on a 3730 DNA
Analyzer (ABI), and genotypes were called by GeneMapper
3.5 (ABI), blind to diagnosis.
Mendelian errors and unlikely genotypes were evaluated
using MERLIN (Abecasis et al. 2002), as described above. We
ﬁrst excluded 19 SNPs because of failed assays and 23 SNPs
because of low call rates (!90%). Then, we excluded 11 SNPs
because of excessive Mendelian errors (11%). The remain-
ing 532 SNPs had 0.017% Mendelian errors per SNP (range
0.00%–0.66%) and 0.044% unlikely recombinants (range
0.00%–0.58%) for all ﬁne-mapping regions (table 1). Two
families were excluded—one because of excessive Mendelian
errors (due to a specimen swap) and one without genotyped
parents, because of excessive unlikely recombinants. The ﬁnal
call rate for all 532 cleaned SNPs was 98.6% (range 92.1%–
100.0%), with a total of 729,158 cleaned genotypes remaining
for further analysis. The average interval between neighboring
SNPs was 0.59 Mb for chromosome 4, 0.53 Mb for chromo-
some 5, 0.64Mb for chromosome 8, 0.69Mb for chromosome
10p, 0.55 Mb for chromosome 10q, and 0.51 Mb for chro-
mosome 11. There were several sizable centromeric gaps where
the genome sequence information was incomplete (a 3.9-Mb
gap for chromosome 5, a 3.8-Mb gap for chromosome 8, and
a 4.1-Mb gap for chromosome 11). The average MAF was
0.35 (range 0.04–0.50) for AA subjects and 0.36 (range 0.00–
0.50) for EA subjects. We also evaluated the repeatability with
121 SNPs from the chromosome 8 ﬁne mapping, in which we
observed repeatability of 99.9% when 268 DNA samples were
blindly regenotyped. Of 31,931 genotypes that were nonzero
in both experiments, 31 were discrepant, with 3 changes in-
volving both alleles in a homozygous subject and 28 others
involving a change of only one of the two alleles in a hetero-
zygous individual.
Deviations from Hardy-Weinberg equilibrium (HWE) were
analyzed separately in EA and AA samples in a set of as many
unrelated individuals as possible. Six SNPs were removed be-
cause of signiﬁcant deviations at in the EA sample, andP ! .01
6 SNPs were likewise removed in the AA sample, including
2 SNPs with highly signiﬁcant deviations in the AA sample
( for rs1355305; for rs896044) (table 1).Pp .00006 Pp .0002
Selection of a Map for Linkage Fine Mapping
We therefore undertook to select a subset of markers for
ﬁne-mapping analyses that had the highest heterozygosity (and
hence the highest IC). Pairwise marker LD between the cleaned
ﬁne-mapping SNPs was analyzed with a set of unrelated indi-
viduals, separately for EA and AA samples, by use of ASSO-
CIATE (Ott 1985), which computes maximum-likelihood es-
timates of the LD parameter by the expectation-maximization
algorithm (Dempster et al. 1977). For example, of 121 SNPs
in the chromosome 8 ﬁne-mapping region, signiﬁcant ( )P ! .05
pairwise LD was observed between 40 and 20 adjacent marker
pairs in the EA and AA samples, respectively, which is consis-
tent with other reports of greater LD in EA than in AA samples
(Hinds et al. 2005).
A contiguous block of highly signiﬁcant LD was observed
in the EA sample across 3.31 Mb (∼6 cM), with six adjacent
SNPs extending from rs2980438 (at 8.132 Mb) to rs7824640
(at 11.442 Mb) on chromosome 8. It appears likely that this
LD block is due to the large polymorphic inversion that is
observed with a frequency 120% in the European (Giglio et
al. 2001; Broman et al. 2003) and Japanese (Sugawara et al.
2003) populations. The inversion typically spans 4.7 Mb be-
tween two low-copy-repeat regions, each of which contains
several olfactory receptor genes (Giglio et al. 2001). Direct
demonstration of the inversion by use of FISH is beyond the
scope of the present study, but we inferred that inversions could
be present in some unknown but substantial proportion of our
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Figure 1 Results of the STRP genome scan for SZ. Zlr scores for the entire sample are plotted on the Y-axis, and genomic position (cM
on CIDR map) by chromosome (p-ter to q-ter) is plotted on the X-axis.
EA subjects on the basis of the large LD block and the fact
that recombination cannot occur between chromosomes that
are heterozygous for an inversion, leading to LD if the inver-
sion is common. We detected no signiﬁcant LD in this region
in AA subjects, which suggests that this inversion is infrequent
in sub-Saharan Africa, similar to the 17q21.31 paracentric in-
version reported recently (Stefansson et al. 2005).
In families with missing parental genotypes, linkage scores
can be inﬂated if substantial LD is present between marker
pairs (Huang et al. 2004; Dunn et al., in press). Recent work
by one of us (Levinson and Holmans, in press) indicates, how-
ever, that there is no appreciable inﬂation of linkage scores if
dense SNP maps are trimmed to eliminate marker pairs whose
LD (as measured by r2) is 10.05. Accordingly, we used this
criterion to trim our SNP maps separately for the EA and AA
families by removing one of each adjacent pair of SNPs that
showed this level of LD. Removal of a SNP will create a new
adjacent pair, and these new pairs were also evaluated for LD,
until all adjacent pairs had r2 estimates !0.05. For chromosome
8, a total of 17 SNPs were trimmed from both EA and AA
families. In the EA families, 12 SNPs were removed because
r2 was 10.05, and 5 were removed because they are located
in the inversion (where there was strong LD). In the AA fam-
ilies, three SNPs were removed because they deviated from
HWE (at ), nine were removed because r2 was 10.05,P ! .01
and ﬁve were removed because they are located in the inver-
sion. We retained a single SNP (hCV1965865) from the in-
version region. However, we deleted this SNP in analyses that
included both SNPs and STRPs, since an STRP in the inversion
(D8S1130) is more polymorphic. Similarly, we had already
deleted the less-informative inversion STRP (D8S1469) for the
combined SNP and STRP analysis, leaving a total of 104 SNPs
and 9 STRPs for the ﬁnal chromosome 8p ﬁne map. Fine-
mapping linkage results are reported for the EA and AA fam-
ilies separately and combined.
For other ﬁne-mapping regions, we followed similar rules
to exclude SNPs that may be in LD with adjacent SNPs (table
1). The ﬁnal numbers of SNPs used in ﬁne-mapping analyses
for the EA and AA samples, respectively, were 64 and 68 for
chromosome 4, 88 and 105 for chromosome 5, 104 and 104
for chromosome 8, 23 and 25 for chromosome 10p, 54 and
59 for chromosome 10q, and 116 and 118 for chromosome
11, for a total of 449 and 479 cleaned ﬁne-mapping SNPs
without signiﬁcant intermarker LD that proceeded to linkage
analyses (table 1).
Correct speciﬁcations of marker-marker genetic distances are
also critical for accurate multipoint linkage analysis. Genetic-
mapping information was not available for most of our ﬁne-
mapping SNPs, and our sample did not include the kinds of
complete and multigenerational pedigrees that ideally should
be used to estimate genetic distances. The deCODE map in-
cludes genetic locations for a larger number of markers, on
the basis of more meioses, than does the CIDRmap. Therefore,
we created a genetic and a physical map of the STRPs in the
region, using the UniSTS database (see UniSTS Web site),
deCODE map information for genetic locations, and the NCBI
sequence map for physical positions. Genetic locations were
assigned to SNPs by use of linear interpolation of physical
positions in relation to the genetic locations of ﬂanking STRPs.
Sharing of Biomaterials and Clinical Data
Biological materials, genotypes, and blinded clinical data will
be made available to the scientiﬁc community by the NIMH
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Table 5
STRPs with a Multipoint Zlr of Nominal Signiﬁcance at P ! .01
CHROMOSOME
AND MARKER ALIAS
POSITION
(cM)a
Zlr
EA Sample AA Sample Total Sample
3:
D3S2406 GGAT2G03 103 2.33 … …
4:
D4S2366 GATA22G05 13 … 2.66 …
D4S403 AFM157xg3 26 … 2.43 …
5:
D5S2848 GATA145D09 40 2.65 … …
D5S1470 GATA7C06 45 2.72 … 2.52
D5S2500 GATA67D03 69 2.37 … …
6:
D6S2427 GGAA15B08 54 … 2.54 …
8:
D8S264 AFM143xd8 1 2.56 … …
D8S262 AFM127xh2 7 3.33 … …
D8S1130 GATA25C10 22 3.06 … …
D8S1106 GATA23D06 26 2.72 … …
D8S1145 GATA72C10 37 3.09 … 2.47
D8S560 AFMa127ye5 43 2.96 … 2.51
D8S1771 AFMb320va5 50 2.95 … 3.24
D8S1477 GGAA20C10 60 … … 2.64
11:
D11S2371 GATA90D07 76 2.66 … 2.74
D11S2002 GATA30G01 85 … … 2.36
20:
D20S851 AFMa218yb5 25 2.34 … …
NOTE.—A nominal is a here.P ! .01 Z 1 2.326lr
a cM values refer to the STRP map of CIDR.
Table 6
STRPs by Map Position and Multipoint Zlr
for Linkage Scan
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Center for Collaborative Genetics Studies of Mental Disorders
(see the Center’s Web site).
Results
We report here results of the clinical characteristics of
the sample, a genomewide linkage scan of SZ, and the
ﬁne mapping of 4p16.3-p15.2, 5p15.2-q13.3, 8p23.3-
q12.1, 10p15.3-p14, 10q25.3-q26.3, and 11p13-q23.3.
Families and Individuals Included in Linkage Analyses
A total of 459 families met eligibility criteria and were
included in the twowaves of CIDR genotyping, although
4 of these families were removed because one of the sib-
lings was no longer considered to be affected after further
diagnostic review in preparation for dimensional analyses.
After removal of families as described above, 409 fami-
lies (408 independent families) were included in the link-
age analysis: 263 (64.3%) EA and 146 (35.7%) AA.
The 409 families resulted from the splitting of 1 family
that was too large to be analyzed by GH. A full de-
scription of the DNA specimens available from this data
set, including those excluded from the present analysis,
will be made available on the NIMH Human Genetics
Initiative for Schizophrenia Web site. Table 2 describes
the number of statistically independent affected full-sib
pairs (AFSPs) and the number of all possible affected
half-sib pairs (AHAPs) used in the linkage analysis. Sta-
tistically independent AFSPs were counted as forS 1
S affected full sibs in a sibship with only full sibs; all
possible AHAPs were counted as for S af-S(S 1)/2
fected half sibs in a sibship with only half sibs. Because
there is no optimal method for counting independent
AHAPs when there are full and half sibs in the same
family, all possible half-sib pairs have been counted in
these cases (see ﬁg. A1 in appendix A for an illustration
and explanation). Linkage analyses included 403 inde-
pendent AFSPs (279 EA and 124 AA), 100 AHAPs (15
EA and 85 AA), and 26 other genotyped affected rela-
tives (parents, aunts, uncles, and offspring). Genotypes
were available for 33% of all parents (45% EA and 17%
AA), and 156 unaffected full or half sibs were genotyped
(96 EA and 60 AA). Linkage analyses included geno-
types from 1,380 subjects.
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Figure 2 Results of the STRP genome scan for SZ on chromosome 8 and the subsequent SNP ﬁne mapping. Positive Zlr scores for the
STRP scan for the entire sample (yellow line), EA subsample (blue line), and AA subsample (red line) are plotted on the Y-axis, and genomic
position (CIDR cM converted to deCODE cM from p-ter, to allow plotting of the ﬁne-mapping data) on chromosome 8 is plotted on the X-
axis (0–80 cM). Similarly, positive Zlr scores for the scanning STRPs plus the ﬁne-mapping SNPs for the entire sample (orange line), EA sample
(green line), and AA sample (purple line) are plotted on the Y-axis, and genomic position (deCODE cM from p-ter) on chromosome 8 is plotted
on the X-axis (0–80 cM). The PPP3CC gene is located at 39 deCODE cM, and the NRG1 (GGF2 isoform) gene spans 53–54 deCODE cM.
The common inversion on chromosome 8p spans ∼18–22 deCODE cM and is marked.
Descriptions of the 1,380 individuals who were geno-
typed are given in tables 3 and 4. Of the 409 families,
263 were EA, and 146 (from 145 independent families)
were AA. The mean age at enrollment was 39.1 and
41.4 years for the EA and AA probands, respectively,
with onset at ∼20 years of age for all groups of male
and female probands, both EA and AA. As noted in table
3, 35% of fathers and 56% of mothers of the EA pro-
bands and 7% of fathers and 33% of mothers of the
AA probands were genotyped. Overall, 4.9% of fathers
and 6.6% of mothers received a diagnosis of SZ, and
1% of mothers received a diagnosis of SA. The “other”
group consisted of 61 half sibs plus other non–ﬁrst-de-
gree relatives. In table 4, we display the characteristics
of probands and siblings with SZ. The percentage of
SZ-affected subjects with a mood disorder did not differ
by ethnicity or between probands and relatives, but fe-
males had a higher percentage than males did (64.5%
vs. 46.2%; ; ). All SA-affected sub-2x p 24.8 P ! .00011
jects had mood episodes (manic, mixed, and/or major
depressive), by deﬁnition.We used a general linearmodel
to examine differences in age at enrollment, age at onset,
duration of psychosis, and duration of mood episodes
in the subjects with SZ and those with SA. The inde-
pendent variables were ethnicity, sex, and familial re-
lationship (probands vs. siblings). Both sex and ethnicity
were signiﬁcant predictors of duration of nonaffective
psychosis ( ), with females and AA subjects havingP ! .01
longer durations. No other variables were signiﬁcant at
the level. There was a trend toward females hav-P ! .01
ing a longer duration of mood episodes ( ). Next,Pp .03
we compared the siblings with SZ and those with SA.
The subjects with SA had a longer duration of mood
episodes ( ). The only other signiﬁcant variableP ! .0001
was ethnicity as a predictor of the duration of nonaffec-
tive psychosis ( ).Pp .02
Genome Scan
For the STRP genome scan, the CIDR map was used,
although, for purposes of display alongside the ﬁne-map-
ping SNPs, we converted to the deCODE map. Figure 1
displays the multipoint Zlr graph across the genome for
all families, and table 5 lists the STRPs that attained a
multipointZlr with nominal signiﬁcance at (resultsP ! .01
for all STRPs are found in table 6). We detected two
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Figure 3 Results of the STRP genome scan for SZ on chromosome 11 and the subsequent SNP ﬁne mapping. Positive Zlr scores for the
STRP scan for the entire sample (yellow line), EA subsample (blue line), and AA subsample (red line) are plotted on the Y-axis, and genomic
position (CIDR cM converted to deCODE cM from p-ter, to allow plotting of the ﬁne-mapping data) on chromosome 11 is plotted on the X-
axis (30–120 cM). Similarly, positive Zlr scores for the scanning STRPs plus the ﬁne-mapping SNPs for the entire sample (orange line), EA
subsample (green line), and AA subsample (purple line) are plotted on the Y-axis, and genomic position (deCODE cM from p-ter) on chromosome
11 is plotted on the X-axis (30–120 cM).
chromosomal regions with suggestive evidence (Z lr
) of linkage in the primary analyses of all families:2.65
8p23.3-p12 and 11p11.2-q22.3. The mean IC for the
STRP scan was 0.60 for the EA sample and 0.55 for the
AA sample.
On chromosome 8p23.3-p12 (ﬁg. 2), Zlr scores 12.0
were observed across 31 cM, from 30.7 to 61.7 cM on
the CIDR map (∼26.6–58.5 cM on the deCODE map
used for ﬁne-mapping analyses; see below). The maxi-
mum multipoint evidence of linkage was a Zlr score of
3.25 (equivalent Kong-Cox LOD of 2.30) nearD8S1771
(at 52 cM). Although the meaning of a 1-LOD interval
is not clear for complex disorders, we note that here the
1-LOD interval (on the CIDR map) extended from 37.0
cM (18.36 Mb, at D8S1145) to 60.3 cM (32.12 Mb, at
D8S1477). The linkage signal in this region was ob-
served primarily in EA families, in which two peaks of
similar magnitude were observed, at 11.5 cM (Z plr
) and at 39.6 cM ( ), with a 1-LOD in-3.52 Z p 3.19lr
terval extending from 2.15 cM (∼3.03 Mb, centromeric
to D8S264) to 58.3 cM (∼30.11 Mb, telomeric to
D8S1477). In AA families, negative Zlr scores were ob-
served from 8pter to 37.0 cM, with a maximum Zlr of
1.55 at 54.2 cM.
Suggestive linkage was also observed in the entire
sample at 11p11.2-q22.3 (ﬁg. 3), with a Zlr of 2.74 at
D11S2371 (76.1 cM; equivalent LOD of 1.63), with a
1-LOD interval from 61.9 cM (∼60.55 Mb, centromeric
to D11S1344) to 94.6 cM (∼94.39 Mb, centromeric to
D11S2000). Again, greater evidence of linkage was ob-
served in EA families ( atD11S2371, 76.1 cM)Z p 2.66lr
than in AA families ( at D11S1391, 104.6Z p 1.61lr
cM).
In the exploratory analysis, uncorrected suggestive
evidence of linkage was observed in AA families on chro-
mosome 4p16.1-p15.32 (ﬁg. 4) and in EA families on
chromosome 5p14.3-q11.2 (ﬁg. 5). For chromosome 4,
the maximum Zlr of 2.72 was at 15.5 cM (6.92 Mb,
centromeric to D4S2366), with a 1-LOD interval from
4pter to 35.5 cM (∼22.65Mb, centromeric toD4S2639)
in AA families. Zlr did not exceed 1.0 in the EA families
on chromosome 4. For chromosome 5, the maximum
Zlr of 2.77 was at 43.2 cM (∼31.61 Mb, telomeric to
D5S1470), with a 1-LOD interval from 33.6 cM (∼17.50
Mb, telomeric to D5S2845) to 74.3 cM (∼66.62 Mb,
telomeric to D5S2500) in EA families. Zlr did not exceed
1.0 in the AA families in this region of chromosome 5.
Linkage Fine-Mapping Analysis
For the ﬁne-mapping analysis, the deCODE map was
used. We performed ﬁne mapping for the four suggestive
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Figure 4 Results of the STRP genome scan for SZ on chromosome 4 and the subsequent SNP ﬁne mapping. Positive Zlr scores for the
STRP scan for the entire sample (yellow line), EA subsample (blue line), and AA subsample (red line) are plotted on the Y-axis, and genomic
position (CIDR cM converted to deCODE cM from p-ter, to allow plotting of the ﬁne-mapping data) on chromosome 4 is plotted on the X-
axis (0–60 cM). Similarly, positive Zlr scores for the scanning STRPs plus the ﬁne-mapping SNPs for the entire sample (orange line), EA subsample
(green line), and AA subsample (purple line) are plotted on the Y-axis, and genomic position (deCODE cM from p-ter) on chromosome 4 is
plotted on the X-axis (0– 60 cM).
regions (4p16.3-p15.2, 5p15.2-q13.3, 8p23.3-q12.1, and
11p13-q23.3) and two other regions that had multiple
markers with a Zlr 12.0 (10p15.3-p14 and 10q25.3-
q26.3) (table 1). The average IC across the ﬁne-mapping
region for EA and AA families was 0.64 and 0.59, re-
spectively, for the STRP map and was 0.85 and 0.79,
respectively, for the map of 104 SNPs and 9 STRPs on
chromosome 8p. The average IC for other ﬁne-mapping
regions for EA and AA families, respectively, was 0.83
and 0.77 for chromosome 4, 0.85 and 0.78 for chromo-
some 5, 0.80 and 0.77 for chromosome 10p, 0.83 and
0.78 for chromosome 10q, and 0.85 and 0.78 for chro-
mosome 11 (table 1).
Figure 2 shows Zlr scores for the full sample and for
EA and AA families separately, with a combination of
STRPs and SNPs on chromosome 8p. In the full sample,
the maximum Zlr score of 3.32 was observed at 44.4
cM (deCODE), just telomeric to D8S1771, where a sim-
ilar peak (Zlrp 3.24) was observed in the scan analysis.
In EA families, two peaks were again observed, although
at slightly different locations than in the scan analysis:
a telomeric peak (Zlr p 3.33) at 16.4 cM (deCODE),
near the boundary of the inversion region (D8S1130),
and a more centromeric peak ( ) at 35.7 cMZ p 3.10lr
(deCODE), telomeric toD8S560. In AA families, a max-
imum Zlr score of 1.68 was observed at 43.1 cM (de-
CODE), contributing to the peak result for the full sam-
ple. Results were essentially identical for analyses with
the SNPs alone.
Therefore, ﬁne mapping did not signiﬁcantly increase
or decrease the overall signiﬁcance or length of the link-
age peak in chromosome 8, despite an increase in IC.
We note that the effect of the inversion on the analysis
remains unclear. The genome-scan map contains two
STRPs in the inversion region, as discussed above. We
removed D8S1469 from the linkage analysis of STRPs
alone (and also in the ﬁne mapping) so that only one
STRP (D8S1130) remained in this region. In EA families,
the peak Zlr in this analysis remains very close to the
inversion region. Until a more comprehensive analysis
of the presence and sequence of inversions in this region
can be performed, their effect on linkage results cannot
be clearly understood. We consider the results of our
analysis of 9 STRPs and 104 SNPs, with only 1 STRP
within the inversion region, to be the most conservative
estimation possible from the present data, and we con-
clude that genomewide suggestive linkage has been ob-
served in the full sample, with two somewhat distinct
peaks observed in the EA families.
However, we observed a more noticeable increase in
signiﬁcance for ﬁne mapping of 5p15.2-q13.3 (ﬁg. 5).
In EA families, the 1-LOD interval was narrowed from
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Table 7
STRPs and SNPs by Map Position and Multipoint Zlr
for Fine-Mapping Regions
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Figure 5 Results of the STRP genome scan for SZ on chromosome 5 and the subsequent SNP ﬁne mapping. Positive Zlr scores for the
STRP scan for the entire sample (yellow line), EA subsample (blue line), and AA subsample (red line) are plotted on the Y-axis, and genomic
position (CIDR cM converted to deCODE cM from p-ter, to allow plotting of the ﬁne-mapping data) on chromosome 5 is plotted on the X-
axis (10–100 cM). Similarly, positive Zlr scores for the scanning STRPs plus the ﬁne-mapping SNPs for the entire sample (orange line), EA
subsample (green line), and AA subsample (purple line) are plotted on the Y-axis, and genomic position (deCODE cM from p-ter) on chromosome
5 is plotted on the X-axis (10–100 cM).
40.7 cM to 31.8 cM (table 1). It became clear that the
centromere separated the linkage region into two peaks,
and the maximum Zlr score of the more signiﬁcant peak
increased from 2.77, telomeric to D5S1470 (43.2 cM
and ∼31.6 Mb) (5p peak), to 3.80 at rs1027164 (73.8
cM and 57.3 Mb) (5q peak) (ﬁg. 5). Zlr did not exceed
1 before or after ﬁne mapping in the AA families (data
not shown).
With regard to the ﬁne mapping of chromosome
4p16.3-p15.2 that showed suggestive linkage in AA fam-
ilies and of chromosome 11p13-q23.3 that showed sug-
gestive linkage in both the EA and the combined sam-
ples, the signiﬁcance remained almost the same as before
ﬁne mapping (table 1 and ﬁgs. 3 and 4). However, we
were able to narrow the 1-LOD interval for chromosome
11 from 32.7 cM to 19.5 cM in the full sample. For
chromosome 10 regions, ﬁne mapping did not improve
any signiﬁcance of linkage beyond a Zlr score of 3 (table
1).
Discussion
Genetic factors appear to predominate in the etiology
of SZ, given a heritability estimated at 0.8. Most studies
of the molecular genetics of SZ have investigated pos-
sible associations with functional polymorphisms in loci
relevant to monoamine neurotransmission, which have
been considered candidate genes on the basis of simple
pharmacological models of SZ. Linkage studies have the
advantage of not depending on any knowledge of the
pathophysiology of the disorder. The most recent meta-
analysis of SZ genome scans, including 20 analyses from
16 individual projects, showed signiﬁcant evidence, across
these studies, of linkage in a number of chromosomal
regions (Lewis et al. 2003). In several of these regions,
plausible candidate genes have been identiﬁed for which
substantial evidence of association with SZ has been re-
ported more than once (Craddock et al. 2005).
We have reported here one of the largest genome scans
of SZ to date. The primary linkage analyses included
predominantly EA or AA families. To take into account
the possibility that these groups might differ in the effects
of different SZ susceptibility loci, separate exploratory
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analyses of EA and AA families were also performed.
Genomewide suggestive evidence of linkage was observed
in the primary analysis on chromosomes 8p23.3-p12 and
11p11.2-q22.3, and, in the exploratory analyses, this
threshold was also exceeded (without correction for mul-
tiple tests) on chromosome 4p16.1-p15.32 in AA families
and on chromosome 5p14.3-q11.2 in EA families.
There are some limitations to our conclusions. For ex-
ample, it is not known how to best deﬁne the phenotype
for genetic studies of SZ. There is considerable support
for the approach of combining the DSM-IV categories of
SZ and SA, on the basis of their high relative risk in
families of probands with SZ compared with the general
population, their similar clinical characteristics in our
(and other) samples, and the high reliability with which
these diagnoses have been assigned. However, more-op-
timal phenotypes or endophenotypes might be identiﬁed
in the future. Furthermore, despite the fact that this is
a very large single sample of pedigrees with SZ, it lacks
sufﬁcient power to reliably detect loci with small effects.
The strongest evidence of linkage was at chromosome
8p23.3-p12. However, the presence of a common para-
centric inversion in our strongest linkage region has com-
plicated our analyses and the interpretation of results.
It is possible, for example, that SZ is associated either
with the presence of certain speciﬁc inversions or with
one or more genes within the inversion segment. Also,
failure to account for the presence of the inversionmight
have inﬂuenced the results of previous linkage analyses
in this region (e.g., the location of the peak signals) in
ways that are not yet clear. We evaluated the sensitivity
of our linkage analyses to the genetic map assumptions,
and linkage results remained basically unchanged what-
ever the assumed order of the SNPs located within the
inverted region. Our results appeared to be more sensi-
tive to the map length. Unsurprisingly, Zlr scores varied
with the assumed length, but these variations remained
relatively moderate. For instance, a twofold decrease in
map length led to a 6% reduction inZlr score. Conversely,
the assumption of a twofold longer map led to a 5%
increase in Zlr score. In spite of these perhaps modest
limitations related to the map effects of the inversion,
evidence of a susceptibility locus for SZ in 8p has been
detected in other family samples (table A3), and two
positional candidate genes—NRG1 and protein phos-
phatase 3 (formerly 2B), catalytic subunit, gamma iso-
form (calcineurin A gamma) (PPP3CC)—have been pro-
posed to account for the linkages (Stefansson et al. 2002;
Gerber et al. 2003), although neither can be considered
deﬁnitively established (for example, see the detailed
analysis of the reported association between NRG1 and
SZ [Duan et al. 2005]). The linkage signal in the present
sample was extremely broad: nine STRP markers across
60 cM produced linkage signals at nominal P ! .01
( ) in the combined sample and in the EA fam-Z 1 2.326lr
ilies separately (table 5). We continued to observe sug-
gestive evidence of linkage in the ﬁne-mapping analysis,
and it is improbable that a denser SNP map would sub-
stantially increase the linkage signal. In the EA families,
which are largely responsible for the positive signal in
this region, there appear to be two peaks. Given this,
plus the repeated observation of evidence of SZ linkage
in this region and the diverse locations of the peak evi-
dence of linkage across studies, there might be more than
one SZ susceptibility gene in this region. The 8p23-p12
region contains 239 annotated genes (UCSC Genome
Bioinformatics, May 2004 freeze); this includes 137 genes
that are annotated as full length, with an initiating ATG
and valid stop-codon, that can be translated from the
genome without frameshifts, and that use consensus
splice sites (Consensus Coding DNA Sequence [CCDS]
database, March 2005 report; see CCDS Web site). In
addition to NRG1 and PPP3CC in 8p, a substantial
number of the genes in this region might be considered
positional candidates because of their roles in brain func-
tion, and, given that the pathophysiology of SZ is largely
unknown, there could be additional relevant genes.
Therefore, large and systematic case-control and/or fam-
ily-based LD mapping experiments should be under-
taken in this region.
In summary, a genome scan of a large sample of ped-
igrees with SZ has produced suggestive evidence of link-
age in two regions and evidence of two other suggestive
regions in exploratory analyses of AA and EA families
(see table 7 for results of ﬁne mapping in our sample).
Some of these regions have support from multiple other
SZ linkage scans (see tables A3 and A4). The present
study increases support for the hypothesis that one, or
possibly more than one, SZ susceptibility gene is located
on chromosome 8p. The SZ candidate regions observed
in multiple samples should be studied systematically in
large samples with the use of LD mapping methods.
Acknowledgments
We thank the patients and families for their participation.
Data and biomaterials from the NIMH Genetics Initiative for
Schizophrenia MGS1 families were collected in nine projects.
From 1999 to 2004, the principal investigators (PIs) and co-
investigators were: University of Chicago, Chicago (grant R01
MH59571): P.V.G. (collaboration coordinator and PI) and
A.R.S.; Baylor College of Medicine, Houston (grant R01
MH59587): F.A. (PI); University of California at Irvine, Irvine
(grant R01 MH60870): W.F.B. (PI); University of Iowa, Iowa
City (grant R01 MH59566): D.W.B. (PI) and R.R.C.; Wash-
ington University, St. Louis (grant R01 MH60879): C.R.C.
(PI); University of Colorado, Denver (grant R01 MH59565):
R.F. (PI) and A.O.; University of Pennsylvania, Philadelphia
330 The American Journal of Human Genetics Volume 78 February 2006 www.ajhg.org
(grant R01 MH61675): D.F.L. (PI), and subcontract to Loui-
siana State University, New Orleans: N.G.B. (subcontract PI);
University of Queensland, Brisbane (grant R01 MH59588):
B.J.M. (PI); and Mt. Sinai School of Medicine, New York
(grant R01 MH59586): J.M.S. (PI). We also thank the indi-
viduals at each participating institution for their laboratory,
database, and/or clinical contributions, especially Roberta
Fishman, Layla Kassem, Eric B. Carpenter, Gregory J. Burrell,
Christos Pantelis, Robert J. Barrett, and Douglas A. Fugman.
Genotyping was performed at CIDR (for STRPs) and at Ev-
anston Northwestern Healthcare Research Institute (for SNPs).
Appendix A
Table A1
Example of Renumbering to Assure that Allelic Designations Are
Comparable between Waves I and II for D6S2427
FRAGMENT
SIZE
(bp)
ALLELE
FREQUENCY
ORIGINAL
ALLELIC
DESIGNATION
RENUMBERED
ALLELIC
DESIGNATION
Wave I Wave II Wave I Wave II Wave I Wave II
187 .003 .003 1 1 1 1
195 .004 … 2 … 2 …
199 .025 .019 3 2 3 3
200 … .002 … 3 … 4
202 .057 … 4 … 5 …
203 … .028 … 4 … 5
206 .116 … 5 … 6 …
207 .003 .148 6 5 7 6
209 … .001 … 6 … 8
210 .283 .247 7 7 9 9
211 .003 .003 8 8 10 10
213 … .001 … 9 … 11
214 .229 .256 9 10 12 12
215 .005 .002 10 11 13 13
218 .153 .153 11 12 14 14
219 … .001 … 13 … 15
222 .060 .072 12 14 16 16
226 .038 .045 13 15 17 17
227 .001 … 14 … 18 …
230 .021 .016 15 16 19 19
234 .001 .002 16 17 20 20
NOTE.—The presence of rare alleles in one wave but not the other
means that the original allelic designations from CIDR cannot be used
when the waves are combined. For instance, allele 10 in wave I has
a frequency of 0.5%, whereas, in wave II, it has a frequency of 25.6%.
In fact, the fragment of size 214 bp (relabled as allele 12 when the
waves are combined) has a frequency of 24.7% in this sample. When
a large proportion of families have ungenotyped parents, as is the case
here, the results of a linkage analysis necessarily will depend on the
estimates of the allele frequencies. Accordingly, when genotypes are
produced in different waves, by different laboratories, or by use of
different technologies, it is critically important to assure that the alleles
align correctly.
Table A2
Example of Allelic Renumbering for D15S128 Used
to Combine the EA and AA Families
FRAGMENT
SIZE
(bp)
ALLELE
NUMBER
ALLELE
FREQUENCY RENUMBERED
ALLELE
(AA ONLY)EA AA
196 1 .0005 … …
198 2 .0011 … …
200 3 .0643 .0141 14
202 4 .0050 .1141 15
204 5 .0050 .1043 16
206 6 .2494 .3424 17
208 7 .2629 .0826 18
210 8 .1661 .1065 19
212 9 .1275 .0576 20
213/214 10 .0833 .0620 21
215/216 11 .0263 .0185 22
217 12 .0062 .0011 23
219 13 .0022 .0032 24
221 14 … .0924 25
225 15 … .0011 26
NOTE.—Shown are the allele frequencies for D15S128 in the EA
and AA families. The original recoding of this STRP resulted in 15
alleles. Alleles 1–13 are the only alleles present in the EA sample.
Accordingly, we renumbered the alleles of the genotypes in the AA
families, as indicated. In the linkage analysis of the combined sample,
the allele frequencies sum to 200%, resulting in the correct compu-
tation of conditional probabilities of the genotypes of missing parents.
Figure A1 Illustration of the counting of sib pairs. Because there
is no optimal method for counting independent affected half sib pairs
when there are full and half sibs in the same family, all possible half
sib pairs (AHAPs) have been counted in these cases. Consider, for
instance, the two families shown here. Pedigree A is counted as two
statistically independent AFSPs and three AHAPs. Pedigree B is
counted as two AFSPs and four AHAPs.
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Table A3
Previous Chromosome 8p SZ Linkage Reports
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Table A4
Previous Chromosome 5 Pericentromeric SZ Linkage
Reports
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Web Resources
The URLs for data presented herein are as follows:
Center for Inherited Disease Research (CIDR), http://www.cidr.jhmi
.edu/
Consensus Coding DNA Sequence (CCDS) database, http://www
.ncbi.nlm.nih.gov/projects/CCDS/ (for March 2005 report)
dbSNP, http://www.ncbi.nlm.nih.gov/SNP/ (for build 34)
HapMap, http://www.hapmap.org/
NIMH Center for Collaborative Genetics Studies of Mental Disorders,
http://zork.wustl.edu/nimh/
NIMH Human Genetics Initiative for Schizophrenia, http://zork
.wustl.edu/nimh/NIMH_initiative/NIMH_initiative_link.html
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm
.nih.gov/Omim/ (for SZ)
UCSCGenome Bioinformatics, http://genome.ucsc.edu/ (forMay 2004
assembly of the human genome)
UniSTS, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dbpunists
(for comprehensive database of sequence-tagged sites)
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